Schedule 13D ownership disclosure
AUTOLUS THERAPEUTICS LTD
Security class unavailable · CUSIP: 05280R100
Event date: 2021-05-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 14,612,275
- Percent of class
- 27.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-21-033764
- Form type
- SC 13D
- Filer
- Autolus Therapeutics plc
- CIK
- CIK 1730463
- Filed
- Jun 23, 2021
- Reporting period
- May 18, 2021
- Description
- Schedule 13D beneficial ownership